Teva agrees to pay $54m fine to settle whistleblower lawsuit
Topics: TEVA FINE WHISTLEBLOWER LAWSUIT
The settlement was announced by the Philadelphia law firm McEldrew Young and Shepherd, which along with the firm Finkelman, Miller and Shah, also of Philadelphia, represented two former Teva sales representatives in the matter.
According to the lawsuit filed in 2013, Teva allegedly induced doctors to write prescriptions for the drugs Copaxone and Azilect, and influenced other doctors to do the same, by paying them as "speakers" or "consultants." Many of the speaker programs, according to the complaint, were "sham events." Copaxone is a multiple sclerosis treatment. Azilect is a Parkinson's disease drug. ■